SCHEMBL3944334

SCHEMBL3944334

Cc1cn(-c2cc(NC(=O)c3ccc(Nc4nccc(Nc5nccs5)n4)cc3)cc(C(F)(F)F)c2)cn1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR2E1 Q9Y466 6/20 0.59
▸ ABL1 P00519 10/20 0.58
▸ BCR P11274 7/20 0.58
▸ ADORA3 P0DMS8 2/20 0.58
▸ NR1I2 O75469 1/20 0.58
▸ PTGS1 P23219 1/20 0.58
▸ KDR P35968 1/20 0.58
▸ CHRNA4 P43681 1/20 0.58
▸ PDE3A Q14432 1/20 0.58
▸ LDLR P01130 3/20 0.58
▸ KIT P10721 3/20 0.58
▸ PCSK9 Q8NBP7 3/20 0.58
▸ PDGFRB P09619 2/20 0.58
▸ EPHB2 P29323 2/20 0.57
▸ HCK P08631 2/20 0.57
▸ EPHB6 O15197 1/20 0.57
▸ CA12 O43570 1/20 0.57
▸ CACNA1F O60840 1/20 0.57
▸ SLC22A3 O75751 1/20 0.57
▸ STK10 O94804 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3949165 0.91 ABL1 (0.70) NR2E1ABL1BCRADORA3NR1I2
SCHEMBL3950634 0.87 ABL1 (0.65) NR2E1ABL1BCRADORA3NR1I2
SCHEMBL3952436 0.86 NR2E1 (0.69) NR2E1ABL1BCRADORA3NR1I2
SCHEMBL3954691 0.86 CSF1R (0.50) NR2E1ABL1BCRADORA3NR1I2
SCHEMBL3947506 0.83 ABL1 (0.69) NR2E1ABL1BCRADORA3NR1I2
SCHEMBL3952869 0.82 ABL1 (0.63) NR2E1ABL1BCRADORA3NR1I2
SCHEMBL3945090 0.81 ABL1 (0.85) NR2E1ABL1BCRADORA3NR1I2
SCHEMBL3944582 0.80 ABL1 (0.85) NR2E1ABL1BCRADORA3NR1I2
SCHEMBL20502615 0.80 ABL1 (0.76) NR2E1ABL1BCRADORA3NR1I2
SCHEMBL3949782 0.80 NR2E1 (0.61) NR2E1ABL1BCRADORA3NR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1922309-B1 N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF IL YANG PHARM CO LTD (KR) 2014-05-21 — — EP disclosed
US-7501424-B2 N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof IL-YANG PHARM. CO., LTD. (KR) 2009-03-10 — — US disclosed
US-20080096899-A1 N-Phenyl-2-Pyrimidine-Amine Derivatives and Process for the Preparation Thereof IL-YANG PHARM. CO., LTD. (KR) 2008-04-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096899-A1 N-Phenyl-2-Pyrimidine-Amine Derivatives and Process for the Preparation Thereof ITPA, TYMP, THPO NR2E1 1951/4885ABL1 451/4885BCR 990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback